To decrease the time and cost of processing urine cultures, we devised a critical pathway to identify and perform antibiotic susceptibility tests on commonly isolated microbial pathogens within 6 h of growth detection. The strategy was based on eliminating expensive kits and automated procedures when not required. A pathway utilizing a statistical matrix and three rapid biochemical tests required to identify the most common pathogen, Escherichia coli, was developed. This species, which represented 82% of urinary isolates, was identified in 1 h for less than 10% the cost of a commercial kit. The specificity of the 1-h E. coli identification battery was .99.9% with a sensitivity of 93%. In addition, this critical pathway, adapting published methods, permitted the identification of other enteric pathogens, the group D streptococci, and Pseudomonas aeruginosa within 4 to 6 h. Furthermore, it accounted for other microbes that required longer periods of incubation. The pathway also included a rapid disk diffusion sensitivity test. Utilizing the critical pathway strategy, 76% (E. coli frequency of 0.82 x E. coli sensitivity of 0.93) of all urinary pathogens were identified within 1 h, and 98% were identified within 4 h with an antibiotic sensitivity test available within 6 h after the observation of growth. Costs were reduced from 2.5 to 5.0 times. This methodology is applicable to other specimen types.
In the last decade we have witnessed a significant growth in the number of laboratory tests carried out per hospitalized patient and an increase in the sophistication and complexity of each individual test. Too often this growth was given impetus by the tendency to axiomatically presume that more was better than less. Costs have increased concomitantly (10) . To address this situation, we devised a critical pathway strategy to reduce costs, increase accuracy, and decrease the time required for identification and antimicrobial susceptibility testing of microbes isolated from urinary tract infections. The method can also be applied to other specimen types. The strategy was based on developing a critical pathway of work flow that would permit the laboratory to specifically identify the most common isolates with the fewest number of tests and in the most rapid time span. Complex, timeconsuming, and expensive procedures required for only a small percentage of laboratory isolates would not be routinely used for all microbes, as is now common practice. A requirement of the strategy was the generation of a completed report for over 95% of isolates within 6 h of the time significant growth was detected.
The urine specimen was Identification of E. coli. By applying an analytical matrix (4, 9) , the number of tests required to identify E. coli specifically were reduced to the following: growth and lactose fermentation on MacConkey agar, indole positivity, cytochrome c oxidase negativity, and ,-glucuronidase positivity.
The indole test was carried out as a spot procedure on filter paper and required 30 s (17) . Kovacs were batch processed. Identification and antibiotic susceptibility proceeded in the following sequence ( Fig. 1) : (i) The rapid spot indole and oxidase tests were performed and recorded. (ii) The test tubes containing p-nitrophenyl-f3-D-glucuronide reagent were inoculated and placed in the incubator. (iii) A 6-h plate antibiotic disk susceptibility test (13) was inoculated and placed in the incubator. (iv) The P-glucuronidase test was read 1 h after inoculation, and the results were recorded. Those microbes that were indole positive, oxidase negative, lactose positive, and ,3-glucuronidase positive were identified as E. coli. Those organisms that were oxidase negative and negative on any other test were considered an enteric pathogen and inoculated into a commercial, 4-h identification system (Micro-ID; General Diagnostics, Warner-Lambert Co., Morris Plains, N.J.). Those organisms that were oxidase positive were considered nonfermenters and were identified as P. aeruginosa by a rapid test (2) or as another species by conventional means (3, 6) . Group D streptococci were identified by rapid tests (7, 8) , and other gram-positive bacteria were identified by conventional tests (7). C. albicans was identified by the 2-h germ tube test, and other yeasts were identified by a commercial product (Analytab Products, Plainview, N.Y.). (v) After 4 h, the Micro-ID tests were read and the enteric pathogens were identified. (vi) The antibiotic susceptibility plates were examined and recorded. If quality control criteria were fulfilled, final reports containing an identification and antibiotic sensitivity were available for 98% of isolates 6 h after initiation of batch processing. (Fig. 1) .
RESULTS
Cost analysis. Table 1 demonstrates the costs incurred to identify enteric pathogens from urine by an average automated system and manual commercial kits, laboratory-prepared and commercially purchased test tube biochemical systems, and the 1-h identification system described here. For purposes of calculation, the commercial systems were considered to yield a definitive diagnosis with no other procedures required; in practice, approximately 5 to 10% of commercial identification tests must be repeated. The Micro-ID 4-h commercial system was calculated as the adjunct identification method to the 1-h E. coli test battery.
The data showed that the 1-h identification system reduced the expenses of identifying E. coli in the urine by a factor of at least 5.0 from the automated commercial, 3.0 from the manual commercial, and 2.5 from the conventional homemade biochemical test tube systems. Overall, total laboratory kit usage was reduced 65%. We calculated the actual savings in our laboratory to be from $30,000 to $32,000 in 1982. DISCUSSION E. coli is the most common microbe isolated in the Clinical Microbiology Laboratory of the Yale-New Haven hospital. It belongs to the family Enterobacteriaceae, of which there are at least 14 genera and over 80 species. Commercial kits are designed to identify all these genera with equal facility. The trend over the last several years has been to perform an increasing number of tests on each isolate to avoid misidentifying a rare or unusual microbe. For the preponderance of clinical laboratory isolates, these tests are unnecessary. The approach taken here was to identify E. coli specifically, rapidly, and inexpensively and only to use commercial systems for the minority of enteric pathogens. Likewise, the group D streptococci and P. aeruginosa were identified by a small number of rapid tests, with the remaining microbes identified by a large series of biochemical tests. A critical pathway for processing specimens automatically directed the work flow to higher levels of complexity when required.
First, we have demonstrated that by choosing the tests to be used with a statistical matrix, E. coli can be identified specifically by the following characteristics: growth and lactose fermentation on MacConkey agar, production of ,B-glucuronidase, production of indole, and lack of production of oxidase. By using these characteristics, there is less than a 0.1% chance that it may be confused with another organism (99.9% specificity). Approximately 7% of E. coli will demonstrate an atypical reaction in any one of these tests (93% sensitivity). However, these isolates are captured by inoculation into the 4-h commercial system, as are all other enteric bacilli (4). Rapid systems have been reported that utilize only growth on MacConkey agar, indole positivity, and oxidase negativity (14) for identification. Without the 3-glucuronidase test, however, there is a sacrifice of specificity for sensitivity. For example, Citrobacter diversus and Klebsiella oxytica may be confused with E. coli (11) .
Second, after designing the minimum number of tests required to identify E. coli and other commonly isolated pathogens, we analyzed cost parameters. Our thesis was that by determining whether an organism was or was not E. coli, a critical pathway could be developed that would obviate the need for using large numbers of commercial, expensive kits. Our data indicated that we eliminated 93% of E. coli kit identifications and reduced kit usage in the laboratory overall by 65%. Because the difference in cost between a commercial or homemade identification system is from 2.5 to 5.0 times more than the 1-h test, substantial savings occurred.
After establishing a specific and inexpensive means of identifying E. coli and other frequent urinary isolates, our third and final goal was to perform it in a time frame that would be rapid and useful for the patient. Initiation of therapy is based on two factors: the name of the organism and the antibiotic susceptibility pattern. There is an association between the species name and its antibiotic susceptibility pattern, and therapy is often started on the basis of microbe identification. Therefore, we felt that to identify an organism specifically and rapidly would aid in the proper therapy and management of the patient. Our system identified E. coli in 1 h, other enteric pathogens in 4 h, and common nonenteric pathogens in 6 h. In addition, our pathway decreased the antibiotic susceptibility test time from 24 to 6 h. It should be mentioned that this scheme, although presented in reference to urine culture, can be used for the identification of E. coli and members of the family Enterobacteriaceae from other body sites.
The 1-h identification method described here allows the specific identification of the most common human pathogen from the human urinary tract, E. coli, in 1 h and the identification of other pathogens that account for 98% of urinary isolates in 4 h. It permits specific treatment based on the name of the organism 24 h before other commonly employed systems. In addition, it is between 2.5 and 5.0 times less expensive than other commonly utilized identification methods.
